Overview

This study is to evaluate the Effectiveness and Safety of Dong-A Opalmon® Tablet in Patients With Acquired Lumbar Spinal Stenosis

Eligibility

Inclusion Criteria:

• Men or women aged ≥ 19 years
• Subjects with acquired Lumbar Spinal Stenosis who show normal results in the Straight Leg Raising (SLR) test and exhibit intermittent claudication, requiring treatment with Dong-A Opalmon® tab
• Subjects who voluntarily consent to participate in this observational study

Exclusion Criteria:

• Subject for whom the medicinal products administration is contraindicated according to the approved domestic drug information: Pregnant women or those who may be pregnant, Subject with genetic disorders such as galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption
• Subjects considered as unsuitable for participation in this observational study by the principal investigator or sub-investigator